GSK plc announced the purchase of 296,202 of its own shares on September 2, 2025, at an average price of 1,450.10p each as part of its ongoing buyback program. This purchase adds to their total of 26,797,755 shares bought since June 4, 2025, leaving the company with 244,932,138 shares in treasury.